AFF3
AF4/FMR2 family member 3
Also known as: AFF3_HUMAN, LAF4, MLLT2-like
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P51826
- Gene
- AFF3
- Ensembl
- ENSG00000144218
- Chromosome
- 2
- Canonical length
- 1226 aa
- Protein class
- Cancer-related genes, Disease related genes, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Cytosol
OverviewNCBI Gene
This gene encodes a tissue-restricted nuclear transcriptional activator that is preferentially expressed in lymphoid tissue. Isolation of this protein initially defined a highly conserved LAF4/MLLT2 gene family of nuclear transcription factors that may function in lymphoid development and oncogenesis. In some ALL patients, this gene has been found fused to the gene for MLL. Multiple alternatively spliced transcript variants that encode different proteins have been found for this gene. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
1226 residues, UniProt reviewed canonical sequence.
>P51826|AFF3
1 MDSFDLALLQ EWDLESLCVY EPDRNALRRK ERERRNQETQ QDDGTFNSSY SLFSEPYKTN
61 KGDELSNRIQ NTLGNYDEMK DFLTDRSNQS HLVGVPKPGV PQTPVNKIDE HFVADSRAQN
121 QPSSICSTTT STPAAVPVQQ SKRGTMGWQK AGHPPSDGQQ RATQQGSLRT LLGDGVGRQQ
181 PRAKQVCNVE VGLQTQERPP AMAAKHSSSG HCVQNFPPSL ASKPSLVQQK PTAYVRPMDG
241 QDQAPDESPK LKSSSETSVH CTSYRGVPAS KPEPARAKAK LSKFSIPKQG EESRSGETNS
301 CVEEIIREMT WLPPLSAIQA PGKVEPTKFP FPNKDSQLVS SGHNNPKKGD AEPESPDNGT
361 SNTSMLEDDL KLSSDEEENE QQAAQRTALR ALSDSAVVQQ PNCRTSVPSS KGSSSSSSSG
421 SSSSSSDSES SSGSDSETES SSSESEGSKP PHFSSPEAEP ASSNKWQLDK WLNKVNPHKP
481 PILIQNESHG SESNQYYNPV KEDVQDCGKV PDVCQPSLRE KEIKSTCKEE QRPRTANKAP
541 GSKGVKQKSP PAAVAVAVSA AAPPPAVPCA PAENAPAPAR RSAGKKPTRR TERTSAGDGA
601 NCHRPEEPAA ADALGTSVVV PPEPTKTRPC GNNRASHRKE LRSSVTCEKR RTRGLSRIVP
661 KSKEFIETES SSSSSSSDSD LESEQEEYPL SKAQTVAASA SSGNDQRLKE AAANGGSGPR
721 APVGSINART TSDIAKELEE QFYTLVPFGR NELLSPLKDS DEIRSLWVKI DLTLLSRIPE
781 HLPQEPGVLS APATKDSESA PPSHTSDTPA EKALPKSKRK RKCDNEDDYR EIKKSQGEKD
841 SSSRLATSTS NTLSANHCNM NINSVAIPIN KNEKMLRSPI SPLSDASKHK YTSEDLTSSS
901 RPNGNSLFTS ASSSKKPKAD SQLQPHGGDL TKAAHNNSEN IPLHKSRPQT KPWSPGSNGH
961 RDCKRQKLVF DDMPRSADYF MQEAKRMKHK ADAMVEKFGK ALNYAEAALS FIECGNAMEQ
1021 GPMESKSPYT MYSETVELIR YAMRLKTHSG PNATPEDKQL AALCYRCLAL LYWRMFRLKR
1081 DHAVKYSKAL IDYFKNSSKA AQAPSPWGAS GKSTGTPSPM SPNPSPASSV GSQGSLSNAS
1141 ALSPSTIVSI PQRIHQMAAN HVSITNSILH SYDYWEMADN LAKENREFFN DLDLLMGPVT
1201 LHSSMEHLVQ YSQQGLHWLR NSAHLSLocalizationUniProt · AlphaFold · HPA
Whether an antibody against AFF3 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.62
- Highest tissue expression
- 15 nTPM
Expression across tissuesHPA
Tissue
- prostate: 15 nTPM
- lymph node: 13 nTPM
- tonsil: 11 nTPM
- cerebellum: 11 nTPM
- breast: 11 nTPM
- bone marrow: 11 nTPM
Single-cell type
- prostatic glandular cells: 3,188 nCPM
- b-cells: 2,597 nCPM
- thyrotrophs: 2,194 nCPM
- breast hormone-responsive cells: 1,980 nCPM
- innate lymphoid cells: 1,468 nCPM
- pdcs: 1,419 nCPM
Immune cell
- naive B-cell: 44 nTPM
- memory B-cell: 31 nTPM
- plasmacytoid DC: 24 nTPM
- myeloid DC: 5.1 nTPM
- naive CD4 T-cell: 1.9 nTPM
- NK-cell: 1 nTPM
Brain region
- cerebellum: 82 nTPM
- cerebral cortex: 72 nTPM
- hippocampal formation: 65 nTPM
- white matter: 64 nTPM
- hypothalamus: 52 nTPM
- basal ganglia: 49 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about AFF3.
Disease | AllUniProt
Conditions AFF3 is implicated in, by any mechanism.
- KINSSHIP syndrome (KINS) MIM:619297
Disease | GeneticClinVar
12 pathogenic / likely-pathogenic of 328 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- KINSSHIP syndrome
- Inborn genetic diseases
- AFF3-associated disorder
- AFF3-related neurodevelopmental disorders
- See cases
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.22
- gnomAD pLI
- 1
- gnomAD missense Z
- 1.71
- DepMap mean gene effect
- -0.15
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads AFF3 as an antibody target. Whether an autoantibody or antibody against AFF3 could matter depends on whether native AFF3 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
AFF3 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label AFF3 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...